Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: Novo Nordisk 12.087, Amgen 10.054.
Novo Nordisk vs Amgen: Revenue Comparison
Novo Nordisk (NVO) and Amgen (AMGN) are peers in GLP-1. Novo Nordisk reported revenue of $12.1B as of Q2 2026, compared with $10.1B for Amgen. Novo Nordisk leads on revenue.
Novo Nordisk's gross margin is 78.2% versus 72.0% for Amgen. Novo Nordisk's net margin is 26.7% versus 23.6% for Amgen.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Novo Nordisk, Amgen.| Metric | Novo Nordisk | Amgen |
|---|---|---|
| Market Cap | - | - |
| Revenue | $12.09B | $10.05B |
| Cost of Revenue | $2.63B | $2.81B |
| Gross Profit | $9.45B | $7.24B |
| Operating Income | $4.17B | $3.51B |
| Net Income | $3.23B | $2.38B |
| R&D Expense | $2.74B | $1.87B |
| Earnings Per Share | $0.73 | $4.37 |
| Gross Margin | 78.2% | 72.0% |
| Operating Margin | 34.5% | 35.0% |
| Net Profit Margin | 26.7% | 23.6% |
| Free Cash Flow | $6.53B | $3.49B |
| Cumulative Free Cash Flow | $107.39B | $169.18B |
| Operating Cash Flow | $8.50B | $4.00B |
| Cash & Equivalents | $6.85B | $13.99B |